Leptin-induced cytosolic phospholipase A₂ activation in gastric mucosal protection against ethanol cytotoxicity involves epidermal growth factor receptor transactivation

Keyphrases

• Ethanol 100%
• Leptin 100%
• Gastric mucosal Protection 100%
• Cytotoxicity 100%
• Cytosolic Phospholipase A2 (cPLA2) 100%
• Epidermal Growth Factor Receptor Transactivation 100%
• Epidermal Growth Factor Receptor 33%
• Prostaglandin E2 22%
• Arachidonic Acid Release 22%
• Phosphorylation 11%
• Protective Effect 11%
• Ethanol-induced Liver Injury 11%
• Gastric mucosal Cells 11%
• Pluripotent 11%
• Prostaglandins 11%
• Tissue Inhibitor of metalloproteinase-1 (TIMP-1) 11%
• Receptor Phosphorylation 11%
• Mucosal Tissues 11%
• AG1478 11%
• Src Kinase Inhibitor 11%
• Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI) 11%
• Src Kinase 11%
• PD98059 11%
• Mucosal Repair 11%
• PGE2 Production 11%
• ERK Inhibitor 11%
• GM6001 11%
• Epidermal Growth Factor Receptor Ligands 11%

Neuroscience

• Transactivation 100%
• Cytotoxicity 100%
• Leptin 100%
• Epidermal Growth Factor Receptor 100%
• Cytosolic Phospholipase A2 100%
• Kinase 22%
• Arachidonic Acid 22%
• Prostaglandin 11%
• Metalloprotease Inhibitor 11%
• Receptor Phosphorylation 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Leptin 100%
• Epidermal Growth Factor Receptor 100%
• Cytosolic Phospholipase A2 100%
• Cytotoxicity 100%
• Arachidonic Acid 22%
• Phosphotransferase 11%
• Cytokine 11%
• Epidermal Growth Factor Receptor Kinase Inhibitor 11%
• Metalloproteinase Inhibitor 11%
• Prostaglandin 11%
• 4 (3 Chloroanilino) 6,7 Dimethoxyquinazoline 11%
• 2 (2 Amino 3 Methoxyphenyl)chromone 11%
• Ilomastat 11%
• 4 Amino 7 Tert Butyl 5 (4 chlorophenyl)pyrazolo[3,4 D]pyrimidine 11%